Hot Stocks to Watch: Amkor Technology, Inc. (NASDAQ:AMKR), CorMedix, Inc. (NYSE:CRMD)

Amkor Technology, Inc. (NASDAQ:AMKR)

The shares of Amkor Technology, Inc. (NASDAQ:AMKR) started off the last trading session with the price of $11.25 while closing the day with the price of $11.29. The shares of Amkor Technology, Inc. (NASDAQ:AMKR) Rise 0.36% with the Gain of 0.04 points.

The shares of Amkor Technology, Inc. (NASDAQ:AMKR) traded with the day volume of 1.42 Million shares whereas its average trading volume is 964.05 Million.

While analyzing the past performance of the stock we can see that the shares of Amkor Technology, Inc. (NASDAQ:AMKR) Loss -1.05% in the last week while rising 9.51% in the last month. Past quarter performance shows the green light with 11.01%. The semi-annual and annual performance shows 19.47% and 3.11% respectively.

Some critical values of the shares of Amkor Technology, Inc. (NASDAQ:AMKR) to be discussed here are: the beta which shows the value at 2.45 while Average True Range of Amkor Technology, Inc. (NASDAQ:AMKR) demonstrate the value at 0.37. The weekly and monthly volatility of the shares of Amkor Technology, Inc. (NASDAQ:AMKR) are indicated at 2.64% and 3.05%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 62.05.

While studying the financial position of the shares of Amkor Technology, Inc. (NASDAQ:AMKR), we can see that the Market capitalization of the company is at 2.69 Billion. The shares outstanding for the company is 238.43 Million and the shares float stands at 101.19 Million. The income of the company stand at 219.2 Million while the sales stand at 4.19 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.91, Price to Earnings or P/E is at 12.35, Price to Sales P/S show the value of 0.64, the Return on Asset ROA stood at 0.06 and the Return on Equity ROE depicted at 0.17 while Return on Investment ROI is at 0.104.


CorMedix, Inc. (NYSE:CRMD)

CorMedix, Inc. (NYSE:CRMD) started its previous trading session at $0.29 and closed at $0.31 showing a Rise of 2.6 Percent.

The Company traded with an average Volume of 1.57 Million whereas, its Day Volume stood at 1.42 Million.

Looking at the performance of the stock, CorMedix, Inc. (NYSE:CRMD) Loss -4.62% in the last week in its shares price and -45.03% in the last month. Quarterly performance shows a red of -46.47 Percent while Semi-Annual and Annual performances shows a -23.43 and -85.13 percent respectively.

Beta for CorMedix, Inc. (NYSE:CRMD) stands at 0.67 while the ATR (average true range) is at 0.04. The Stock’s Weekly and Monthly Volatility is 7.74% and 13.33% respectively showing a RSI value of 38.26.

While studying the financial position of the shares of CorMedix, Inc. (NYSE:CRMD), we can see that the Market capitalization of the company is at 20.09 Million. The shares outstanding for the company is 65.26 Million and the shares float stands at 62.98 Million.

The Company generated an income of -29100000 and the sales of 400000 in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.61 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 50.22 respectively.

The Return on Assets stands at -1.618, ROE shows a value of -2.16 and ROI for CorMedix, Inc. (NYSE:CRMD) is 0 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment